6505--Contingency Pharmacy Compounding Products-Services 36C25626Q0026

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36C25626Q0026
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Central Arkansas Veterans Healthcare System Inpatient Pharmacy 7D-136 Little Rock AR 72205, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration is soliciting quotes for contingency pharmacy compounding products and services, specifically aseptically compounded hazardous chemotherapy agents and related pharmaceutical supplies for the Central Arkansas Veterans Healthcare System. This unrestricted procurement seeks an FDA 503A-compliant pharmacy capable of preparing patient-specific chemotherapy preparations, IV tubing, and closed system drug transfer devices with next-day delivery by 9 AM to the VA medical center's inpatient pharmacy. Key contractor qualifications include current pharmacy licenses, compliance with USP standards (797, 795, and 800), no pending FDA consent decrees, and demonstrated capability in hazardous chemotherapy compounding with appropriate courier training. The VA will evaluate quotes using a comparative approach considering technical capability, past performance, and price as equally weighted factors. Critical deadlines include October 28, 2025 at 10:00 AM CST for submission of questions to Contracting Officer Anthony Marion, and November 7, 2025 at 10:00 AM CST for quote submissions via email to anthony.marion2@va.gov.

This is an unrestricted procurement with no set-aside designation, and no incumbent contractor is identified in the solicitation documents. The contract will establish a Not-to-Exceed (NTE) amount for each year, with the contractor invoicing only for contract line items actually utilized; the comprehensive price schedule covers an extensive range of chemotherapy agents and related pharmaceutical supplies across multiple pricing tiers for the base year and four option years. The five-year performance period extends from December 26, 2025 through December 25, 2030, providing significant potential contract value for a qualified vendor. The place of performance is the Inpatient Pharmacy located at 4300 West 7th Street, Building 7D-136, in Little Rock, Arkansas. The solicitation is issued under simplified acquisition procedures for commercial items utilizing NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1,300 employees.

Notice text

Solicitation Number: 36C25626Q0026

1. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, in conjunction with FAR Part 13.5 Simplified Acquisition Procedures for Certain Commercial Items as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued.

2. This solicitation document incorporates provisions and clauses are those in effect through FAC 2025-06 (eff. 10/01/2025) VAAR DEVIATION APR 2025 (eff. 04/01/2025),VAAM Alert 26-01 (eff. 10/01/2025) Acquisition Policy Flash 25-30 eff. 09/18/2025).

3. This requirement is solicited as unrestricted. The North American Industry Classification System number is 325412 with a size standard in number of 1300.

4. Place of Performance: Central Arkansas Veterans Healthcare System, 4300 West 7th Street, Inpatient Pharmacy, 7D-136, Little Rock, AR 72205.

5. Period of Performance: December 26, 2025 to December 25, 2030.

6. All questions regarding this solicitation shall be submitted via email to Anthony Marion at anthony.marion2@va.gov no later than 10:00am. Central Standard Time on 10/28/2025.

7. Quotes are due no later than 11/7/2025 at 10:00am (CST) and shall be submitted electronically via e-mail to anthony.marion2@va.gov.

8. Please review solicitation in its entirety, review instructions to offeror and evaluation factors.

The following provisions apply to this acquisition: The provision at 52.212-1 Introduction to Offerors Commercial, applies to this acquisition.

The provision at 52.212-2 ADDENDUM, EVALUATION COMMERCIAL ITEMS (Nov 2021) apply to this acquisition.

All offers shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items.

The clause at 52.212-4, Contract Terms and Conditions Commercial Items, applies to this acquisition and a statement. The addendum to FAR 52.212-4 also applies to this acquisition.

The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items, applies to this acquisition and all additional FAR clauses cited in the clause are applicable to the acquisition.

Addendum to FAR 52.212-4 shows FAR clauses followed by VAAR clauses in numeric order.

Solicitation contains a list of all clauses incorporated by reference in numeric order under 52.252-2 (see below), starting first with FAR and followed by VAAR.

Files

Notice history

Notice Type Posted
6505--Contingency Pharmacy Compounding Products-Services 36C25626Q0026 Award Award Notice
This notice Latest solicitation Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Bayesian Dosing Software Salt Lake City, Utah 84148, United States · NAICS 513210 Veterans Integrated Service Network 19 Total Small Business
Sterile Compounding Services Texas 78229, United States · NAICS 541380 Veterans Integrated Service Network 17 Service-Disabled Veteran-Owned Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors